MEDNAX Inc
NYSE:MD
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
6.77
16.08
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
MEDNAX Inc
MEDNAX Inc
Net Issuance of Debt
MEDNAX Inc
Net Issuance of Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
MEDNAX Inc
NYSE:MD
|
Net Issuance of Debt
-$15.1m
|
CAGR 3-Years
73%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Net Issuance of Debt
$1.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Net Issuance of Debt
$2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
60%
|
CAGR 10-Years
16%
|
|
|
CVS Health Corp
NYSE:CVS
|
Net Issuance of Debt
$3.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
5%
|
|
|
Cigna Corp
NYSE:CI
|
Net Issuance of Debt
$1.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Net Issuance of Debt
$1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
41%
|
CAGR 10-Years
13%
|
|
MEDNAX Inc
Glance View
MEDNAX, Inc. engages in the provision of physician services. The company is headquartered in Sunrise, Florida and currently employs 2,725 full-time employees. The firm provides neonatal care, which provides clinical care to babies born prematurely or with complications within specific units at hospitals, primarily neonatal intensive care units (NICUs), through its network of affiliated neonatal physician subspecialists (neonatologists), neonatal nurse practitioners and other pediatric clinicians. The company offers maternal-fetal care, which provides inpatient and office-based clinical care to expectant mothers and their unborn babies through its affiliated maternal-fetal medicine subspecialists as well as obstetricians and other clinicians, such as maternal-fetal nurse practitioners and certified nurse mid-wives. The company provides other pediatric subspecialty care services, which includes other pediatric subspecialists, such as, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists.
See Also
What is MEDNAX Inc's Net Issuance of Debt?
Net Issuance of Debt
-15.1m
USD
Based on the financial report for Sep 30, 2024, MEDNAX Inc's Net Issuance of Debt amounts to -15.1m USD.
What is MEDNAX Inc's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 5Y
22%
Over the last year, the Net Issuance of Debt growth was 86%. The average annual Net Issuance of Debt growth rates for MEDNAX Inc have been 73% over the past three years , 22% over the past five years .
You don't have any saved screeners yet
